A Clinical Trial to Evaluate the Effects of Peptide Gummies on Markers of Inflammation, Physical Performance, and Recovery

This study will evaluate the effects of Parlay Recover peptide gummies (containing BodyProtection Compound BPC‐157) on markers of inflammation, physical performance, andrecovery in physically active adults. Over an 8‐week period, 40 participants will consumetwo gummies daily and complete questionnaires at Baseline, Week 2, Week 4, Week 6, andWeek 8, as well as undergo blood testing at Baseline and Week 8.The primary objective is to examine changes in inflammatory biomarkers (hs‐CRP and IL‐6)as measured by blood testing. Secondary objectives include evaluating participants'self‐reported perceptions of the product's effects on physical performance and recovery,including aching, stiffness, function, and recovery of muscles and joints.